Folgende News gab Albo heute raus. Die Jahreszahlen werden fünf Tage später veröffentlicht als geplant. Für mich kein Grund, mich groß zu sorgen.
ir.albireopharma.com/static-files/...12-45b7-9053-de32170a08b0
The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion
thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on
Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed
due date; and
PART III
NARRATIVE
State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within
the prescribed time period.
Albireo Pharma, Inc. (the “Company”) was not able to file its Annual Report on Form 10-K for the year ended December 31, 2017 (the “Annual Report”) in a
timely manner (i.e., on or before March 16, 2018). The Company requires additional time due to pervasive material weaknesses in its controls over financial
reporting and the Company’s continued analysis of its income tax disclosures and foreign currency translation adjustments associated with its consolidation
process. As a result, the Company was unable to file its Form 10-K for the year ended December 31, 2017 by the prescribed due date without unreasonable
effort or expense. The Company anticipates that the Form 10-K for the year ended December 31, 2017 will be filed as soon as practicable and prior to the
fifteenth calendar day following the prescribed due date.